Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Bullboard Posts
Comment by Trennamon Aug 08, 2018 9:11am
66 Views
Post# 28426109

RE:RE:RE:Clinical trial approval

RE:RE:RE:Clinical trial approval


It's keeping investors informed of what the company is doing (not some silly NR meant to drive up share price.. why do some people always think every NR should drive up share price anyway?)

Also keeping in mind the last few recent NR that shows Canopy folding everything under its umbrella - CHI and CHA.

Not forgetting the other monster partnership: Canopy Beckley.

Marc Wayne is the man who is quoted in this announcement (remember the dude who started Bedrocan Canada right? Yeah that Marc.)

So as I snuggle up with my kitties, one being an elder girl - I want clinical / science backed studies, papers, trials and eventually properly formulated medicine for all animals. (To go along with the clinical studies Canopy is doing on human ailments like the sleep study right now.)

Let's have a bit of science to go along with our MJ instead of the stereotypical stoner nonsense and stygma.

Oh and... monetize and make MONEY off of the products from these trials - bottom line!






slightfan1 wrote: just to clarify, yes the market could be very big but a NR to announce that they are starting clinical trials that might take years and not even pan out???

smells like grasping at straws.


 

Bullboard Posts